CD8A and ovarian serous adenocarcinoma: For instance, in patients with advanced high-grade serous ovarian cancer (HGSOC), elevated levels of CD57+CD8+ in ascites but not in peripheral blood were linked to poor prognosis and resistance to chemotherapy [43].